These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10520732)

  • 1. Effects of 50mg amisulpride on EEG, psychomotor and cognitive functions in healthy sleep-deprived subjects.
    Patat A; Rosenzweig P; Miget N; Allain H; Gandon JM
    Fundam Clin Pharmacol; 1999; 13(5):582-94. PubMed ID: 10520732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single oral doses of amisulpride do not enhance the effects of alcohol on the performance and memory of healthy subjects.
    Mattila MJ; Patat A; Seppälä T; Kalska H; Jalava ML; Vanakoski J; Lavanant C
    Eur J Clin Pharmacol; 1996; 51(2):161-6. PubMed ID: 8911882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers.
    Rosenzweig P; Canal M; Patat A; Bergougnan L; Zieleniuk I; Bianchetti G
    Hum Psychopharmacol; 2002 Jan; 17(1):1-13. PubMed ID: 12404702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychomotor, Cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpride) and a classic (haloperidol) antipsychotic.
    Ramaekers JG; Louwerens JW; Muntjewerff ND; Milius H; de Bie A; Rosenzweig P; Patat A; O'Hanlon JF
    J Clin Psychopharmacol; 1999 Jun; 19(3):209-21. PubMed ID: 10350027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amisulpride: a review of its use in the management of schizophrenia.
    Curran MP; Perry CM
    Drugs; 2001; 61(14):2123-50. PubMed ID: 11735643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tiapride on electroencephalograms and cognitive functions in the elderly.
    Patat A; Alberini H; Bonhomme D; Soubrane C; Allain H; Gandon JM
    Int Clin Psychopharmacol; 1999 Jul; 14(4):199-208. PubMed ID: 10468312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.
    Schoemaker H; Claustre Y; Fage D; Rouquier L; Chergui K; Curet O; Oblin A; Gonon F; Carter C; Benavides J; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):83-97. PubMed ID: 8996185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on amisulpride in schizophrenia.
    Curran MP; Perry CM
    CNS Drugs; 2002; 16(3):207-11. PubMed ID: 11888341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride: from animal pharmacology to therapeutic action.
    Scatton B; Claustre Y; Cudennec A; Oblin A; Perrault G; Sanger DJ; Schoemaker H
    Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S29-36. PubMed ID: 9218165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute effects of amisulpride (50 mg and 200 mg) and haloperidol (2 mg) on cognitive function in healthy elderly volunteers.
    Legangneux E; McEwen J; Wesnes KA; Bergougnan L; Miget N; Canal M; L'Heritier C; Pinquier JL; Rosenzweig P
    J Psychopharmacol; 2000 Jun; 14(2):164-71. PubMed ID: 10890311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amisulpride: a review of its use in the management of schizophrenia.
    McKeage K; Plosker GL
    CNS Drugs; 2004; 18(13):933-56. PubMed ID: 15521794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].
    Pélissolo A; Krebs MO; Olié JP
    Encephale; 1996; 22(3):215-9. PubMed ID: 8767050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new slow release formulation of caffeine on EEG, psychomotor and cognitive functions in sleep-deprived subjects.
    Patat A; Rosenzweig P; Enslen M; Trocherie S; Miget N; Bozon MC; Allain H; Gandon JM
    Hum Psychopharmacol; 2000 Apr; 15(3):153-170. PubMed ID: 12404329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
    Wetzel H; Gründer G; Hillert A; Philipp M; Gattaz WF; Sauer H; Adler G; Schröder J; Rein W; Benkert O
    Psychopharmacology (Berl); 1998 Jun; 137(3):223-32. PubMed ID: 9682999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of risperidone on psychometric and cognitive functions in healthy elderly volunteers.
    Allain H; Tessier C; Bentué-Ferrer D; Tarral A; Le Breton S; Gandon M; Bouhours P
    Psychopharmacology (Berl); 2003 Feb; 165(4):419-29. PubMed ID: 12459926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive improvement in schizophrenic patients does not require a serotonergic mechanism: randomized controlled trial of olanzapine vs amisulpride.
    Wagner M; Quednow BB; Westheide J; Schlaepfer TE; Maier W; Kühn KU
    Neuropsychopharmacology; 2005 Feb; 30(2):381-90. PubMed ID: 15578006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].
    Chabannes JP; Pelissolo A; Farah S; Gerard D
    Encephale; 1998; 24(4):386-92. PubMed ID: 9809244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of negative symptoms in schizophrenia with amisulpride.
    Boyer P; Lecrubier Y; Puech AJ; Dewailly J; Aubin F
    Br J Psychiatry; 1995 Jan; 166(1):68-72. PubMed ID: 7894879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.